Stanford Study of Breast Cancer Reveals Heterogeneity of Early Lesions, Recurrent PIK3CA Mutations | GenomeWeb

NEW YORK (GenomeWeb) – Researchers at Stanford University studying the development of breast cancer in individuals have found that early lesions are genetically heterogeneous and that mutations in a well-known cancer gene, PIK3CA, induce cell growth but don't always lead to cancer.

The study, published online today in Genome Medicine, proposes the mutational analysis of pre-cancerous lesions in the clinic and raises questions about the utility of PIK3CA as a diagnostic marker of cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Dec
08
Sponsored by
Personal Genome Diagnostics

This online seminar will discuss the application of circulating tumor DNA (ctDNA) sequencing to evaluate the emergence of resistance mutations during therapy.